Do you want to read an article? Please log in or register.
Short-acting β(2)-agonists (SABA) overuse in asthma and patients' perceptions for this behavior
Asthma
RECOMMENDED
Related content
Asthma
Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Initiation in Japanese Patients with Asthma Previously on Inhaled Corticosteroid/Long-Acting β(2)-Agonist Therapy: A Retrospective Cohort Study
J Clin Med
Oga T, Gon Y, Takano M, Ito R, Mita C, Mukai I, Noorduyn SG, Requena G, Yarita M
doi: 10.3390/jcm14082566
COPD
Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β(2)-agonist: post-hoc analyses of KRONOS
Respir Res
Singh D, Bafadhel M, Arya N, Marshall J, Parikh H, Kisielewicz D, Movitz C, Bowen K, Patel M
doi: 10.1186/s12931-025-03234-5
RECOMMENDED
Asthma
Patterns of Rescue and Maintenance Medication Claims Surrounding an Asthma Exacerbation in Patients Treated as Intermittent or Mild Persistent Asthma
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Lanz MJ, Pollack M, Gilbert IA, Gandhi HN, Tkacz JP, Lugogo NL
doi: 10.2147/JAA.S470975
RECOMMENDED
Asthma
Key Characteristics of Asthma Patients with COVID-19 Vary Substantially by Age
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Asthma Allergy
Kirui BK, Santosa A, Li H, Vanfleteren LEGW, Stridsman C, Nyberg F
doi: 10.2147/JAA.S456145
RECOMMENDED
Asthma
Asthma Control and Associated Factors Among Children with Current Asthma - Findings from the 2019 Child Behavioral Risk Factor Surveillance System - Asthma Call-Back Survey
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Asthma Allergy
Habte BM, Beyene KA, Patel SA, Fenta TG, Fitzpatrick AM
doi: 10.2147/JAA.S465550
ERS 2024
Asthma
BEHAVE: Benralizumab reduces exacerbations and improves asthma control in real-world patients with severe asthma
RECOMMENDED
Asthma
Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Wechsler ME, Brusselle G, Virchow JC, Bourdin A, Kostikas K, Llanos JP, Roseti SL, Ambrose CS, Hunter G, Jackson DJ, Castro M, Lugogo N, Pavord ID, Martin N, Brightling CE
doi: 10.1183/13993003.00316-2024
COMMENTED
Asthma
Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Castro M, Papi A, Porsbjerg C, Lugogo NL, Brightling CE, González-Barcala FJ, Bourdin A, Ostrovskyy M, Staevska M, Chou PC, Duca L, Pereira AM, Fogarty C, Nadama R, Zhang M, Rodrigues A, Soler X, Sacks HJ, Deniz Y, Rowe PJ, de Prado Gómez L, Jacob-Nara JA
doi: 10.1016/S2213-2600(24)00362-X
RECOMMENDED
Asthma
Risk Factors Associated with Asthma Control and Quality of Life in Patients with Mild Asthma Without Preventer Treatment, a Cross-Sectional Study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Eriksson S, Giezeman M, Hasselgren M, Janson C, Kisiel MA, Montgomery S, Nager A, Sandelowsky H, Ställberg B, Sundh J, Lisspers K
doi: 10.2147/JAA.S460051